Financial Performance - The company's operating revenue for Q3 2024 was ¥34,864,134.05, representing a 16.01% increase compared to the same period last year[2]. - The net profit attributable to shareholders was -¥9,732,912.71, with a year-to-date net profit of -¥37,809,461.12, reflecting a significant decline of 273.47% year-on-year[2][7]. - Total operating revenue for the first three quarters of 2024 was CNY 92,494,786.38, a decrease of 43.3% compared to CNY 163,340,532.08 in the same period of 2023[17]. - Net profit for the first three quarters of 2024 was a loss of CNY 37,809,461.12, compared to a net profit of CNY 21,795,411.93 in the same period of 2023[18]. - The total comprehensive income attributable to the parent company was -37,809,461.12 RMB, compared to 21,795,411.93 RMB in the same period last year[19]. - Basic and diluted earnings per share were both -0.51 RMB, down from 0.38 RMB in the previous year[19]. Research and Development - The R&D investment for the current period was ¥13,571,043.39, which is an increase of 31.99% compared to the previous period, and R&D expenses accounted for 38.93% of operating revenue, up 4.72 percentage points[4][7]. - Research and development expenses increased to CNY 38,551,093.06 in the first three quarters of 2024, up from CNY 27,680,132.08 in 2023, reflecting a growth of 39.1%[17]. Assets and Liabilities - The total assets at the end of the reporting period were ¥1,031,383,823.17, showing a decrease of 3.28% from the previous year[4]. - The total assets as of the end of the third quarter of 2024 were CNY 1,031,383,823.17, a decrease from CNY 1,066,314,809.40 at the end of the third quarter of 2023[15]. - Total liabilities increased to CNY 59,401,517.99 in the third quarter of 2024, compared to CNY 43,996,727.23 in the same period of 2023, marking an increase of 35.0%[15]. - The total equity attributable to shareholders was ¥971,982,305.18, down 4.92% from the previous year[4]. Cash Flow - The net cash flow from operating activities for the year-to-date period was -¥36,088,217.74, indicating a decrease due to declining revenue and increased operational expenses[2][7]. - Cash inflow from operating activities totaled 97,259,491.82 RMB, a decrease of 43.6% from 172,641,680.45 RMB in the previous year[20]. - Cash outflow from operating activities was 133,347,709.56 RMB, down from 198,078,760.68 RMB in the same period last year[22]. - The company's cash and cash equivalents decreased from RMB 394,139,173.27 at the end of 2023 to RMB 193,163,715.43 as of September 30, 2024, a decline of approximately 51%[13]. - The ending balance of cash and cash equivalents was 193,163,715.43 RMB, down from 594,546,939.27 RMB in the previous year[22]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period is 7,309[9]. - The largest shareholder, Ding Guohua, holds 11,198,042 shares, representing 15.20% of the total shares[9]. - The company has a significant shareholder, Guangdong Ganhua Science and Technology Co., Ltd., holding 10,555,216 shares, which is 14.32% of the total shares[9]. - The top ten shareholders collectively hold 35.47% of the company's shares[10]. - The company has not reported any significant changes in shareholder relationships or actions among the top shareholders[10]. Market and Strategic Outlook - The company has faced intensified industry competition and longer ramp-up periods for new fields or clients, impacting revenue growth[7]. - The company plans to focus on expanding its market presence and enhancing product development in the upcoming quarters[16]. - The increase in sales expenses to CNY 12,424,672.29 in 2024 from CNY 6,773,295.00 in 2023 indicates a strategic push for market penetration[17]. Accounting and Standards - The company did not apply new accounting standards or interpretations that would affect the financial statements for the year[23].
锴威特(688693) - 2024 Q3 - 季度财报